Several more common neurodevelopmental conditions such as fetal alcohol spectrum disorders or autism spectrum disorders with the evidence for the role of MeCP2 in their molecular biology of disease (Liyanage et al., 2015, 2017; Rastegar, 2017a; Amiri et al., 2020) may also benefit from the results of our study. This evidence concerns the gene MECP2 and autism spectrum disorder.